The progress of fundamental research on the histopathological and mole
cular genetic properties, model systems, growth factor involvement, an
d tumor markers of clinical nephroblastoma (Wilms' tumor) are reviewed
. Histologically, Wilms' tumor (WT) has been found to reveal a disorga
nized renal developmental process in which blastema and epithelia are
randomly interspersed in varying amounts of stroma. Anaplasia is the o
nly criterion for assigning a WT as having an ''unfavorable histology.
'' Cytogenetic analysis identified WT genes at chromosome 11p13 (WT1),
11p15 region (WT2), and 16q (WT3). Permanent in vitro WT cell lines a
nd in vivo WT models, such as human xenografts, have been established
which provide indefinite sources of tumor material for fundamental, as
well as therapy-directed, research. Abnormalities of growth factor (G
F) expression in WT indicate that GF may play an important role in WT
pathogenesis. A series of monoclonal antibodies was tested in WT by im
munohistochemical techniques to identify specific diagnostic and progn
ostic markers. p53 expression in anaplastic WT is significantly higher
than in differentiated WTs, indicating p53 may be a prognostic marker
. Although significant progress has been made in the fundamental resea
rch, our basic knowledge of this malignancy is still limited. The avai
lability of suitable experimental models, particularly the human xenog
raft system, offers the opportunity for further study of the cell biol
ogical and molecular aspects of WT and its clinical progression.